These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 31802250)
1. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study. Kim SH; Suh Y; Ah YM; Jun K; Lee JY Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study. Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926 [TBL] [Abstract][Full Text] [Related]
3. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital. Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276 [TBL] [Abstract][Full Text] [Related]
4. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap. Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501 [TBL] [Abstract][Full Text] [Related]
5. Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea. Song YK; Oh JM Support Care Cancer; 2020 Aug; 28(8):3711-3720. PubMed ID: 31820128 [TBL] [Abstract][Full Text] [Related]
6. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions. van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444 [TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes Associated with Drug-Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review. Sharma M; Vadhariya A; Chikermane S; Gopinathan S; Chavez-MacGregor M; Giordano SH; Johnson ML; Holmes HM Drugs Aging; 2019 Apr; 36(4):341-354. PubMed ID: 30714077 [TBL] [Abstract][Full Text] [Related]
8. Real world co-prescribing contraindicated drugs with fluconazole and itraconazole. Je NK; Youm S; Chun P Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):752-762. PubMed ID: 36812157 [TBL] [Abstract][Full Text] [Related]
9. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software. Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate. Jamani R; Lee EK; Berry SR; Saluja R; DeAngelis C; Giotis A; Emmenegger U Eur J Clin Pharmacol; 2016 Nov; 72(11):1391-1399. PubMed ID: 27561266 [TBL] [Abstract][Full Text] [Related]
11. Association of inappropriate polypharmacy with emergency department visits in older patients receiving anti-neoplastic therapy: a population-based study. Suh Y; Ah YM; Lee E; Lee JY Support Care Cancer; 2021 Jun; 29(6):3025-3034. PubMed ID: 33037903 [TBL] [Abstract][Full Text] [Related]
12. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Wong CM; Ko Y; Chan A Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481 [TBL] [Abstract][Full Text] [Related]
13. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors. Oliveira RF; Oliveira AI; Cruz AS; Ribeiro O; Afreixo V; Pimentel F BMC Geriatr; 2024 Jun; 24(1):557. PubMed ID: 38918696 [TBL] [Abstract][Full Text] [Related]
14. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Lin CF; Wang CY; Bai CH Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763 [TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. Sheikh-Taha M; Asmar M BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442 [TBL] [Abstract][Full Text] [Related]
16. Drug-drug interactions in pediatric oncology patients. Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734 [TBL] [Abstract][Full Text] [Related]
18. Drug interactions between chemotherapeutic regimens and antiepileptics. Yap KY; Chui WK; Chan A Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983 [TBL] [Abstract][Full Text] [Related]
19. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation. Rodrigues J; Marques P; Gomes C; Portela C Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248 [TBL] [Abstract][Full Text] [Related]
20. Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians. Chan A; Yap KY; Koh D; Low XH; Cheung YT; Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):939-47. PubMed ID: 21732473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]